CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
Go back to CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 8.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.43 | 52 Week High | $4.54 | |||
| Open | $8.43 | 52 Week Low | $1.15 | |||
| Day High | $8.43 | P/E | N/A | |||
| Day Low | $8.43 | EPS | $-0.55 | |||
| Volume | 256 | |||||

